Vol. 1 · No. 43

Clinical Neurophysiology

Navigated TMS Protocol Maps Language Lateralization in Both Hands

A NeuroImage protocol paper details an MRI-guided navigated TMS method for language production lateralization, tested in right- and left-handed individuals.

By Marcus Bennett4 min

Updated

MRI-guided navigated TMS protocol for language production lateralization in right- and left-handed individuals
MRI-guided navigated TMS protocol for language production lateralization in right- and left-handed individuals — GregMontani / pixabay
EEG SignalClinical Neurophysiology

A protocol paper published online 25 September 2026 in NeuroImage lays out an MRI-guided navigated transcranial magnetic stimulation method for lateralizing language production, and tests it across both right- and left-handed individuals. The study comes from Cristina Cano-Melle, Miriam Lluesma-Martín, Cristina Narganes-Pineda, Joaquín J. Ramírez-Guerrero, Ana B. Chica and César Avila, a team spanning neurophysiology and cognitive neuroscience groups in Spain.

For clinical neurophysiology readers, the appeal is straightforward. Language lateralization before epilepsy surgery or resection near eloquent cortex still runs through the Wada test or task-based functional MRI in most centers. Both carry costs. The Wada is invasive. fMRI is indirect, task-dependent and sometimes inconclusive in patients with language reorganization. Navigated TMS offers a third path: a frameless stereotactic mapping technique that uses the patient's own MRI to target stimulation and record behavioral interference at named cortical sites.

The authors' focus on handedness matters for practice. Left-handed and ambidextrous patients show higher rates of atypical or bilateral language dominance, which is precisely the population where noninvasive preoperative estimates fail most often. Building and validating the protocol in both right- and left-handed individuals addresses the group where the clinical need is sharpest.

What does the protocol change for the reading room and mapping lab?

The paper is a methods contribution, not a regulatory milestone. Navigated TMS systems from major manufacturers hold FDA clearance for pre-surgical mapping of motor and language cortex, so the technique itself sits in established clinical territory in the United States, with broader routine use in Europe. What Cano-Melle and colleagues add is a specified, reproducible stimulation-and-recording procedure for language production — the output side of language that verb-generation and naming tasks probe — rather than the more commonly mapped comprehension or motor functions.

For teams already running navigated TMS programs, the practical questions are procedural:

  • How many stimulation sites per hemisphere, and at what spacing, the protocol prescribes
  • What language production task runs during stimulation, and how errors are scored
  • How handedness affected lateralization outcomes between the two groups studied

These details determine whether a lab can adopt the protocol directly or must adapt its existing task battery, coil placement conventions and error-classification scheme.

How does it compare with current standards?

No single noninvasive modality has displaced the Wada test across the field. Task fMRI remains the most common first-line tool. MEG offers temporal resolution that TMS lacks but demands specialist infrastructure. Navigated TMS occupies a distinct niche: it delivers a causal interference signal — disrupt cortex, observe the behavioral consequence — rather than a correlational activation pattern. That causal logic is what gives TMS mapping its persuasive weight in surgical planning conferences.

The trade-offs are familiar to anyone running a mapping service. TMS language mapping takes chair time. Error scoring requires trained observers and blinded video review in well-run studies. Pediatric applicability remains limited relative to fMRI. And lateralization conclusions are only as strong as the sampling grid and the statistical criterion the protocol fixes.

What is established and what is investigational?

Readers should keep the evidentiary tiers separate. The hardware is cleared for clinical mapping. Specific protocols for a given language function, in a given handedness stratum, remain study-level evidence until independently replicated and compared head-to-head against Wada or fMRI in surgical cohorts. This NeuroImage paper is human-subject methods work; it is not an animal study and not a device trial. Its claim is that the protocol works and yields interpretable lateralization data across right- and left-handed participants — no more, no less.

The handedness dimension also carries a research dividend. Atypical dominance estimates in the literature vary widely depending on the measurement technique. A TMS-based estimate, with its causal interference signature, gives cognitive neuroscientists an anchor point against which fMRI lateralization indices in left-handers can be calibrated.

Where this goes next

The natural next step is validation in a clinical population — epilepsy surgery candidates, tumor patients — with lateralization outcomes checked against Wada procedures, electrocortical stimulation mapping at surgery, or postoperative language outcomes. Until that work appears, the protocol is best read as a well-specified tool ready for comparative testing, and a sign that language production mapping by navigated TMS is maturing from proof of concept toward standardized clinical procedure.

Based on

Source: NeuroImage (Elsevier).

Share this article:

Marcus Bennett

Show full bio

Staff writer covering technology and product news in Clinical neurophysiology and EEG interpretation at EEG Signal.

More from Marcus Bennett →

Further reading

« Previous articleNext article »